The drug-delivery device, which is still in the development stages, would be able to last up to 16 years in a woman's body, delivering 30 micrograms a day of levonorgestrel to the upper arms, buttocks or abdomen.
While other birth control implants, like IUDs, need to be removed by medical professionals, the chip could be turned on and off with minimal effort.
According to the Massachusetts Technology Review,
The chip will be ready for preclinical testing in 2015, with the aim of making it available to the public in 2018.
Most Popular Stories
- James Foley Beheading Video Is Real Thing: White House
- McDonald's Packages Coffee for National Distribution
- Apple Stock Bounces Back Big Time
- Faith Groups Divest From Fossil Fuels
- Notes From the July FOMC Meeting
- Castro-Blanco Joins Fifth Street Finance Board
- Honda's Safe Approach Pays Off in Sales
- Ballmer Steps Down From Microsoft Board
- GE Healthcare Bringing Jobs to Massachusetts
- Target Slashes Annual Profit Outlook